Back to mobile site

More on TARS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-390.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tarsus Pharmaceuticals (NQ:TARS)
Delayed: 72.08 +1.58 (2.24%)
Prev. Close $70.50  
Open$70.93 
52 Wk High$ 
52 Wk Low$ 
Day High$73.11 
Day Low$69.55 
P/E N/A  
EPS$ 
Volume688,651 

Friends, Peers and Foes (?): ACHV MANE (more...)

Oct 14, 2026 04:05 PM Lisata Therapeutics adds Jeffrey Farrow to its board of directors
Oct 14, 2026 04:05 PM Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Oct 13, 2026 05:05 PM Tarsus Pharmaceuticals (TARS) files for up to 2.91M share offering by selling stockholders
Oct 13, 2026 05:03 PM Form S-3ASR Tarsus Pharmaceuticals,
Oct 13, 2026 04:32 PM Tarsus Pharmaceuticals (TARS) files for up to 2.23M share offering by selling stockholders
Oct 13, 2026 04:30 PM Form S-3ASR Tarsus Pharmaceuticals,
Oct 13, 2026 04:01 PM Form 8-K/A Tarsus Pharmaceuticals, For: Sep 04
Sep 29, 2026 08:30 AM Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
Sep 24, 2026 05:00 AM Goldman Sachs Assumes Tarsus Pharmaceuticals (TARS) at Buy
Sep 17, 2026 04:48 PM Form 4 Tarsus Pharmaceuticals, For: Sep 15 Filed by: PYOTT DAVID E I
View All Articles

Entities mentioned with TARS

View All Entities